Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT05034250
Eligibility Criteria:
Women with infertility
Inclusion criteria:
* The patient suffers from primary or secondary infertility, defined as the inability to conceive despite frequent unprotected sexual intercourse for at least 12 months.
* The patient has given her written informed consent after detailed information on the study by medical professionals at the Department of Obstetrics and Gynecology of the Medical University of Vienna.
* The patient is \>18 and \<40 years old.
Exclusion criteria:
* Inflammatoric bowel disease, cardiac insufficiency, chronic kidney disease, any malignant diseases.
* Polycystic ovary syndrome.
* There is no "informed consent".
Women with recurrent miscarriage
Inclusion criteria:
* The patient suffers from recurrent miscarriage, defined as three or more consecutive miscarriages before the 20th gestation week with the same partner.
* The patient has given her written informed consent after detailed information on the study by medical professionals at the Department of Obstetrics and Gynecology of the Medical University of Vienna.
* The patient is \>18 and \<40 years old.
Exclusion criteria:
* Inflammatoric bowel disease, cardiac insufficiency, chronic kidney disease, any malignant diseases.
* Polycystic ovary syndrome
* There is no "informed consent".
Healthy controls
Inclusion criteria:
* The woman does neither suffer from infertility/sterility nor from recurrent miscarriage and is also otherwise healthy with regular cycles.
* The patient has given her written informed consent after detailed information on the study by medical professionals at the Department of Obstetrics and Gynecology of the Medical University of Vienna.
* The patient is \>18 and \<40 years old.
Exclusion criteria:
* Inflammatoric bowel disease, cardiac insufficiency, chronic kidney disease, any malignant diseases.
* Polycystic ovary syndrome
* There is no "informed consent".
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT05034250
Study Brief:
Protocol Section:
NCT05034250